|Bid||82.09 x 1100|
|Ask||82.13 x 800|
|Day's Range||81.24 - 82.34|
|52 Week Range||46.78 - 84.03|
|Beta (5Y Monthly)||1.23|
|PE Ratio (TTM)||155.24|
|Earnings Date||Apr 24, 2023 - Apr 28, 2023|
|Forward Dividend & Yield||0.32 (0.39%)|
|Ex-Dividend Date||Dec 14, 2022|
|1y Target Est||86.94|
Subscribe to Yahoo Finance Plus to view Fair Value for GE
Nearly 10% of CEOs from companies that make up the S&P 500 share a Cincinnati connection. The Standard and Poor's 500 stock market index tracks the performance of 500 large companies, and 9.1% of the CEOs of those companies trace their roots to Procter & Gamble (NYSE: PG), according to a new report – "The Role of the CEO 2023" – from global people intelligence firm Altrata. P&G was second among companies whose alumni held the top spot at S&P 500 firms, just behind General Electric, whose former employees make up 10.2% of CEOs of companies on the index.
The recent spinoff of General Electric's (NYSE: GE) healthcare unit, known as GE HealthCare Technologies (NASDAQ: GEHC), has been a hit with investors. Underscoring this point, GE Healthcare's shares have jumped by a healthy 16.6% since their debut on the Nasdaq stock exchange a little over a month ago. Here is the bull-vs.-bear take on GE Healthcare's near-term prospects as a growth vehicle.
The newly listed healthcare company gave its first set of earnings as a stand-alone company, and while there were some negatives, its future looks bright.